Table 2.
Variable | Total (%) | Asian (%) | Caucasian (%) | Log rank |
---|---|---|---|---|
Overall | 46.4 | 54.1 | 46.1 | 0.001 |
Age | ||||
≥59 | 42.3 | 47.3 | 42.2 | 0.050 |
BMI (n = 6764) | ||||
<25 | 44.5 | 49.4 | 44.2 | 0.024 |
≥25 | 43.6 | 65.6 | 43.2 | 0.004 |
Performance status | ||||
0 | 51.4 | 55.9 | 51.3 | 0.047 |
1 | 40.5 | 51.8 | 40.2 | 0.02 |
2/3 | 27.8 | 40.7 | 27.4 | 0.77 |
FIGO stage | ||||
I | 89.0 | 89.1 | 89.0 | 0.69 |
II | 80.7 | 63.5 | 81.2 | 0.48 |
III | 43.4 | 47.9 | 43.2 | 0.18 |
IV | 25.5 | 36.9 | 25.0 | 0.045 |
Histology | ||||
Serous | 41.6 | 50.5 | 41.3 | 0.006 |
Clear-cell | 59.9 | 61.3 | 59.8 | 0.64 |
Endometrioid | 67.3 | 64.9 | 67.3 | 0.77 |
Mucinous | 55.8 | 77.8 | 54.4 | 0.34 |
Adenocarcinoma | 66.7 | 100.0 | 65.8 | 0.25 |
NOS mixed | 52.8 | 33.3 | 53.5 | 0.09 |
Epithelial other | 49.3 | 66.7 | 48.8 | 0.21 |
Tumor grade (differentiation) | ||||
1 | 61.7 | 73.3 | 61.4 | 0.38 |
2 | 43.1 | 41.3 | 43.2 | 0.98 |
3 | 44.5 | 53.8 | 44.2 | 0.007 |
Ungraded | 64.1 | 68.3 | 63.6 | 0.42 |
Gross residual disease | ||||
Yes | 32.9 | 41.6 | 32.5 | 0.02 |
No | 58.9 | 64.9 | 58.7 | 0.03 |